Emergence of Low-Molecular-Weight Heparins in Cardiology

Emergence of Low-Molecular-Weight Heparins in Cardiology

Drug therapy for the management of acute coronary syndromes is rapidly expanding. Over the past few years, a number of new antithrombotic agents have been introduced, including low‐molecular‐weight heparins. The epidemiology and pathophysiology of acute coronary syndromes are discussed, with a histo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacotherapy 1999-09, Vol.19 (9P2), p.141S-146S
1. Verfasser: Stringer, Kathleen A.
Format: Artikel
Sprache:eng
Schlagworte:
Acute Disease
Clinical Trials as Topic
Coronary Disease - drug therapy
Coronary Disease - epidemiology
Coronary Disease - etiology
Fibrinolytic Agents - therapeutic use
Forecasting
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Drug therapy for the management of acute coronary syndromes is rapidly expanding. Over the past few years, a number of new antithrombotic agents have been introduced, including low‐molecular‐weight heparins. The epidemiology and pathophysiology of acute coronary syndromes are discussed, with a historical perspective on the use of antithrombotic therapy.
ISSN:0277-0008
1875-9114
DOI:10.1592/phco.19.14.141S.31706